Literature DB >> 18560356

Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells.

L L Song1, Y Peng, J Yun, P Rizzo, V Chaturvedi, S Weijzen, W M Kast, P J B Stone, L Santos, A Loredo, U Lendahl, G Sonenshein, B Osborne, J-Z Qin, A Pannuti, B J Nickoloff, L Miele.   

Abstract

Notch-1 inhibits apoptosis in some transformed cells through incompletely understood mechanisms. Notch-1 can increase nuclear factor-kappa B (NF-kappaB) activity through a variety of mechanisms. Overexpression of cleaved Notch-1 in T-cell acute lymphoblastic leukemia cells activates NF-kappaB via interaction with the I kappa B kinase (IKK) signalosome. Concomitant activation of the Notch and NF-kappaB pathways has been described in a large series of cervical cancer specimens. Here, we show that wild-type, spontaneously expressed Notch-1 stimulates NF-kappaB activity in CaSki cervical cancer cells by associating with the IKK signalosome through IKKalpha. A significant fraction of tumor necrosis factor (TNF)-alpha-stimulated IkappaB kinase activity in CaSki cells is Notch-1-dependent. In addition, Notch-1 is found in the nucleus in association with IKKalpha at IKKalpha-stimulated promoters and is required for association of IKKalpha with these promoters under basal and TNF-alpha-stimulated conditions. Notch-1-IKKalpha complexes are found in normal human keratinocytes as well, suggesting that IKK regulation is a physiological function of Notch-1. Both Notch-1 and IKKalpha knockdown sensitize CaSki cells to cisplatin-induced apoptosis to equivalent extents. Our data indicate that Notch-1 regulates NF-kappaB in cervical cancer cells at least in part via cytoplasmic and nuclear IKK-mediated pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560356     DOI: 10.1038/onc.2008.190

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Blocking IKKα expression inhibits prostate cancer invasiveness.

Authors:  Rubi Mahato; Bin Qin; Kun Cheng
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

4.  Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-κB signaling.

Authors:  Yuan Liu; Chuanfu Su; Yuqing Shan; Shouxiang Yang; Guifeng Ma
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 5.  The different faces of Notch in T-helper-cell differentiation.

Authors:  Derk Amsen; Andrey Antov; Richard A Flavell
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

6.  Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells.

Authors:  Zhong Chen; Carter Van Waes; Xin Xin Quan; Nga Voong Hawk; Weiping Chen; Jamie Coupar; Steven K Lee; David W Petersen; Paul S Meltzer; Andrew Montemarano; Martin Braun
Journal:  Mol Cancer Ther       Date:  2018-06-29       Impact factor: 6.261

Review 7.  The role of NOTCH1 signaling in T-ALL.

Authors:  Adolfo A Ferrando
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 8.  Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Adolfo Ferrando
Journal:  Clin Lymphoma Myeloma       Date:  2009

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

10.  Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

Authors:  L Hao; P Rizzo; C Osipo; A Pannuti; D Wyatt; L W-K Cheung; G Sonenshein; B A Osborne; L Miele
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.